| NHD | Nasu-Hakola disease |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| CNS | Central Nervous System |
| TREM2 | Triggering Receptor Expressed on Myeloid Cells 2 |
| DAP12 | DNAX activation protein 12 |
| IL | Interleukin |
| ALS | amyotrophic lateral sclerosis |
| ITAM | Immunoreceptor Tyrosine-based Activation Motif |
| SH2 | src homology domain-2 |
| Syk | Spleen tyrosine kinase |
| EAE | Experimental autoimmune encephalomyelitis |
| NF-κB | Nuclear factor-κB |
| TLR | Toll like receptor |
| LPS | Lipopolisaccaride |
| DCs | Dendritic cells |
| TNF | Tumor necrosis factor tumor necrosis factor |
| NOS2 | NO Synthase-2 |
| IFN | Interferon |
| ADAM10 | Metalloproteinase domain-containing protein 10 |
| FTD | Frontotemporal dementia |
| CSF | Cerebrospinal fluid |
| NDMA | N-methyl-d-aspartate receptor |
| GABA | γ-aminobutyric acid |
| NO | Nitric oxide |
| AR | Adenosine receptor |
| SCI | Spinal cord injury |
| MDMs | Monocyte-derived macrophages |
| SIRT1 | Sirtuin1 |
| PKA | AMP-dependent protein kinase A |
| APOE | Apolipoprotein E. |